Shield Therapeutics PLC | Key People and Executives
Carl Sterritt
Chief Executive Officer & Executive Director
Hans-Peter Hasler
Non-Executive Director
Rolf K. Hoffmann
Independent Non-Executive Director
Peter Llewellyn-Davies
Independent Non-Executive Director
James M. Karis
Independent Non-Executive Director
Carl Sterritt
Chief Executive Officer & Executive Director
Karl David Keegan
CFO & Director-Corporate Development
Mark Sampson
Chief Medical Officer
David Childs
Director-Product Supply & Commercial Alliances
Hans-Peter Hasler
Non-Executive Director
Suzanne Wood
Director-Group Human Resources
Lucy Bailey
Secretary & Legal Counsel
Jackie Mitchell
Vice President-Regulatory Affairs & Quality
Rolf K. Hoffmann
Independent Non-Executive Director
Peter Llewellyn-Davies
Independent Non-Executive Director
James M. Karis
Independent Non-Executive Director
| Address |
Northern Design Centre
Gatehead Quays GH NE8 3DF
United Kingdom
|
|
Employees
|
- |
| Website |
http://shieldtherapeutics.com |
| Updated |
07/08/2019 |
| Shield Therapeutics Plc is a pharmaceutical company. It engages in the development and commercialization of secondary care focused pharmaceuticals. Its products include Feraccru, which treats oral problems with iron deficiency anaemia; and PT20, which treats hyperphosphatemia. |
